US Patent 7794715 Anti-TIRC7 antibodies in therapy of inflammatory diseases
Patent 7794715 was granted and assigned to CellAct Pharma GmbH on September, 2010 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7794715 Anti-TIRC7 antibodies in therapy of inflammatory diseases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.